These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8552433

  • 1. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens.
    Kari MA, Akino T, Hallman M.
    Pediatr Res; 1995 Nov; 38(5):676-84. PubMed ID: 8552433
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens.
    Kari MA, Raivio KO, Venge P, Hallman M.
    Pediatr Res; 1994 Sep; 36(3):387-93. PubMed ID: 7808837
    [Abstract] [Full Text] [Related]

  • 3. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
    Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS.
    Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
    [Abstract] [Full Text] [Related]

  • 4. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
    Hallman M, Merritt TA, Akino T, Bry K.
    Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
    [Abstract] [Full Text] [Related]

  • 5. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure.
    Hallman M, Merritt TA, Pohjavuori M, Gluck L.
    Pediatr Res; 1986 Dec; 20(12):1228-35. PubMed ID: 3797115
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS.
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE, Simonato M, Mariatoffolo G, Stefanutti G, Chierici M, Cobelli C, Ori C, Carnielli VP.
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [Abstract] [Full Text] [Related]

  • 8. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M, Sardesai S, McEvoy C.
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [Abstract] [Full Text] [Related]

  • 9. Repeat surfactant therapy for postsurfactant slump.
    Katz LA, Klein JM.
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [Abstract] [Full Text] [Related]

  • 10. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AG, Kessler DL, Little GA, Edwards WH, Vidyasagar D, Raju TN.
    N Engl J Med; 1989 Apr 13; 320(15):959-65. PubMed ID: 2648150
    [Abstract] [Full Text] [Related]

  • 11. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP, Egberts J, de Kleine MJ, van Bel F, Wijnands JB, Guit GL.
    Ned Tijdschr Geneeskd; 1992 Oct 10; 136(41):2018-24. PubMed ID: 1407193
    [Abstract] [Full Text] [Related]

  • 12. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.
    Wang JY, Yeh TF, Lin YC, Miyamura K, Holmskov U, Reid KB.
    Thorax; 1996 Sep 10; 51(9):907-13. PubMed ID: 8984701
    [Abstract] [Full Text] [Related]

  • 13. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD, Beharry K, Padilla G, Iriye B.
    J Perinatol; 1996 Sep 10; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [Abstract] [Full Text] [Related]

  • 14. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
    Salvo V, Zimmermann LJ, Gavilanes AW, Barberi I, Ricotti A, Abella R, Frigiola A, Giamberti A, Florio P, Tagliabue P, Tina LG, Nigro F, Temporini F, Gazzolo D.
    Pediatr Crit Care Med; 2012 Jan 10; 13(1):72-9. PubMed ID: 21499177
    [Abstract] [Full Text] [Related]

  • 15. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
    Farrell EE, Silver RK, Kimberlin LV, Wolf ES, Dusik JM.
    Am J Obstet Gynecol; 1989 Sep 10; 161(3):628-33. PubMed ID: 2675599
    [Abstract] [Full Text] [Related]

  • 16. Surfactant status in preterm neonates recovering from respiratory distress syndrome.
    Verlato G, Cogo PE, Balzani M, Gucciardi A, Burattini I, De Benedictis F, Martiri G, Carnielli VP.
    Pediatrics; 2008 Jul 10; 122(1):102-8. PubMed ID: 18595992
    [Abstract] [Full Text] [Related]

  • 17. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V.
    N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms to explain surfactant responses.
    Jobe AH.
    Biol Neonate; 2006 Dec 12; 89(4):298-302. PubMed ID: 16770069
    [Abstract] [Full Text] [Related]

  • 19. Human surfactant in the treatment of respiratory distress syndrome. A spectrum of clinical responses.
    Hallman M, Pohjavuori M, Järvenpää AL, Bry K, Merritt TA, Pesonen E.
    Eur Respir J Suppl; 1989 Mar 12; 3():77S-80S. PubMed ID: 2663000
    [Abstract] [Full Text] [Related]

  • 20. Inositol supplementation in premature infants with respiratory distress syndrome.
    Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M.
    N Engl J Med; 1992 May 07; 326(19):1233-9. PubMed ID: 1560798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.